Levels of non-HDL-C reflect the total circulating pool of atherogenic lipid factors and have been associated with ongoing plaque progression on statin treatment. It is unknown whether these levels modulate… Click to show full abstract
Levels of non-HDL-C reflect the total circulating pool of atherogenic lipid factors and have been associated with ongoing plaque progression on statin treatment. It is unknown whether these levels modulate the degree of regression observed with addition of a proprotein convertase subtilisin kexin
               
Click one of the above tabs to view related content.